Pharmaceuticals

Aptamers Market Expansion Outlook: $7.87 Billion by 2029 Forecast

November 7, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Predicted Market Size Trajectory For The Aptamers Market From 2025 To 2034?

The aptamers market has observed substantial expansion in recent years. It is anticipated to expand from $2.65 billion in 2024 to $3.25 billion in 2025, achieving a compound annual growth rate (CAGR) of 22.6%. This historical growth can be attributed to several factors including the demand for high-specificity binders, their therapeutic potential, the emergence of personalized medicine, their applicability across various therapeutic areas, their utility as antibody alternatives, and their integration into diagnostic point-of-care (POC) devices.

The aptamers market is anticipated to show significant expansion in the next few years, projected to reach “$7.87 billion in 2029, with a compound annual growth rate (CAGR) of 24.7%.” This growth during the forecast period is fueled by elements such as increased investment in life sciences, an expansion in drug development efforts, a rise in cancer research, the demand for rapid detection in emergency settings, advancements in aptamer selection techniques, and supportive regulatory frameworks. Prominent trends for this period include innovations in selex technology, a growing number of applications in diagnostics, greater investment in aptamer research, the integration of technology with nanotechnology, and various awareness and education initiatives.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8156&type=smp

What Are The Drivers Pushing New Developments In The Aptamers Market?

The increasing prevalence of chronic respiratory diseases is projected to drive the expansion of the aptamers market. These conditions are characterized by narrowed and swollen airways, often producing excess mucus, which makes breathing difficult and causes symptoms like coughing, shortness of breath, and wheezing. Aptamers play a crucial role in detecting the respiratory syncytial virus (RSV), aiding in early disease identification, and facilitating treatment. For example, according to the Australian Institute of Health and Welfare in June 2024, COPD represented 3.6% of the total disease burden and 50% of the disease burden related to respiratory conditions in 2023. In 2022, COPD was identified as the underlying cause of 7,691 deaths, equating to 29.6 per 100,000 population, and accounted for 4.0% of all deaths in Australia. Therefore, the rising prevalence of chronic respiratory diseases is a significant factor propelling the growth of the aptamers market.

What Are The Major Segments Identified In The Aptamers Market?

The aptamers market covered in this report is segmented –

1) By Type: DNA Aptamers, XNA Aptamers, RNA Aptamers

2) By Technology: SELEX, X Aptamer, Maras Technique

3) By Application: Therapeutics Development, Research and Development, Diagnostic, Other Applications

4) By End User: Pharmaceutical And Biotechnology Companies, Academic And Government Research Institutes, Cathode-Ray Oscilloscope, Other End Users

Subsegments:

1) By DNA Aptamers: Single-Stranded DNA (ssDNA) Aptamers, Double-Stranded DNA (dsDNA) Aptamers

2) By XNA Aptamers: Peptide Nucleic Acid (PNA) Aptamers, Locked Nucleic Acid (LNA) Aptamers, Glycyl Nucleic Acid (GNA) Aptamers

3) By RNA Aptamers: Small Interfering RNA (siRNA) Aptamers, Short Hairpin RNA (shRNA) Aptamers, Long Non-Coding RNA (lncRNA) Aptamers

How Are Emerging Market Trends Shaping The Aptamers Industry Landscape?

Technological advancements are emerging as the principal trends gaining traction within the aptamers market. Prominent companies active in this market are deploying novel technologies, such as artificial DNA aptamers, crafted with adaptable and integrated methods to uphold their market presence. For example, in August 2023, the FDA granted approval to Izervay for addressing geographic atrophy secondary to age-related macular degeneration. Izervay presents a new avenue for managing the progression of geographic atrophy, instilling hope for patients coping with this advanced form of macular degeneration. The treatment seeks to retard the degeneration of retinal cells associated with the ailment, representing a crucial stride in vision care.

Which Global Market Leaders Are Shaping The Future Of The Aptamers Sector?

Major companies operating in the aptamers market are Aptamer Group Limited, SomaLogic Inc., Aptamer Sciences Inc., Aptagen LLC, NeoVentures Biotechnology Inc., Aptus Biotech, Base Pair Biotechnologies Inc., AMS Biotechnology Ltd., Vivonics Inc., TriLink Biotechnologies LLC, Noxxon Pharma SE, AM Biotechnologies LLC, Raptamer Discovery Group, Kaneka Corporation, Novaptech Inc., Maravai Lifesciences Inc., Bio-Techne Corporation, Creative Biolabs Inc., IBA Lifesciences GmbH, Aptabharat Innovations Pvt. Ltd., Profacgen Biotech Inc., Medi GmbH & Co. KG, Pure Biologics Sp. z o.o., Oak BioSciences Inc., Ophthotech Corporation, Novartis AG, NeoNeuro SAS, CAGE Bio Inc., TAGCyx Biotechnologies Inc., AstraZeneca PLC, GlyTech Inc., GC Biopharma Corp., Achiko AG, Agilent Technologies Inc., IVERIC bio Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/aptamers-global-market-report

Which Regional Markets Are Contributing Most To The Aptamers Industry Expansion?

North America was the largest region in the aptamers market in 2024. The regions covered in the aptamers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Aptamers Market Report:

https://www.thebusinessresearchcompany.com/customise?id=8156&type=smp

Browse Through More Reports Similar to the Global Aptamers Market 2025, By The Business Research Company

Nucleic Acid Based Gene Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/nucleic-acid-based-gene-therapy-global-market-report

Oligonucleotides Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/oligonucleotides-therapy-global-market-report

Point Of Care Molecular Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/point-of-care-molecular-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795